GAD65, the rate-limiting enzyme for GABA synthesis, has been well described in relation to autoimmune conditions, including, but not limited to, diabetes mellitus type-1 (DM-1), pernicious anemia (PA), autoimmune thyroiditis, seizure disorders, and SPS [4-7]. Here, GAD2 is linked to stiff-person syndrome.